focus -WSS

focus

author：leisure time 2025-10-01 17:57:09 - browse：4

The home health industry lobbying group is suing Medicare over new payment cuts. But profits in the sector remain near all-time highs. Business Insider/AP

The National Association of Home Care and Hospice sued the Biden administration to halt the government’s recent proposed rule that would cut Medicare payments to home health agencies by 2.2% in 2024.

Since 2020, Medicare has updated its system for how it pays for home health, in particular by basing payments less on how much therapy someone is getting at home. By law, the new system can’t cost more or less than it otherwise would have, but Medicare reinforced this year that it had “paid more under the new system than it would have under the old system” — and thus continued cuts to home health for next year.

Newsletters

Sign up for STAT Health Care Inc.

Following the flow of money through the health care industry.

Please enter a valid email address. Privacy Policy

NAHC, the home health industry’s lobbying group, said in its lawsuit that Medicare has been violating the requirement to keep things “budget-neutral” and threatens to put home health operators out of business. But one thing NAHC failed to mention: Profits in the home health industry remain near all-time highs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Stephen Quake on the Chan Zuckerberg quest to conquer disease

Wikipedia

knowledge

WSS

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Hospitals need to get ahead of regulations on climate change

NIH tests clinical research in primary care with $30 million program

Louisiana bill approved classifying abortion pills as controlled substances

Moderna says combo Covid

Readers discuss the intersection of pregnancy and addiction

knowledge

focus

Sign up for STAT Health Care Inc.

hotspot

Jerome Adams on the need for new antivirals for Covid

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Guidelines to prevent youth baseball injuries need more muscle

Clinicians often fail to acknowledge the pain caused by long Covid

Medical leaders decry Supreme Court decision on affirmative action

California wildfire smoke linked to 52,000 early deaths, study says

BioMarin wins approval for gene therapy to treat hemophilia A

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Medicare details structure of new drug price negotiation program

Report captures long Covid’s disabling effects and policy challenges

explore

Guardant Health colon cancer test endorsed by FDA advisory panel

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

New report analyzes digital physical therapy solutions' effectiveness

Curing rare childhood diseases will falter unless Congress steps up

Lilly's Alzheimer's drug donanemab backed by FDA advisers

The system is set up to fail children with medical complexity

leisure time

Wikipedia

knowledge

Wikipedia